Table 4.
Follow-up after abnormal PSA values
| Reference number | Country | PSA Cut off (ng/ml) | Referral (%) | Repeat test (%) | No action (%) | PSA > 10 referral (%) |
|---|---|---|---|---|---|---|
|
Database studies |
|
|
|
|
|
|
| [14] |
USA |
PSA ≥ 4 |
51.9 |
|
48 |
|
| |
|
Age-specific cut off: |
58 |
|
42 |
|
| 6.5 (≥ 75 yr) | ||||||
| [24] |
Spain |
PSA ≥ 4 |
31 |
|
69 |
|
| [21] |
USA |
PSA ≥ 4 |
86 |
56.1 |
|
100 |
|
Survey studies |
|
|
|
|
|
|
| [23] |
UK |
PSA ≥ 3 |
18.2 |
15.7 |
67 |
82.7 |
| |
|
PSA ≥ 4 |
30 |
|
|
|
| |
|
Mean (calculated) |
28.6 |
|
|
71.4 |
| 50–59 yr: 6.2 | ||||||
| 70–84 yr: 13 | ||||||
| [18] |
France |
NS |
10.5 |
|
|
|
| [26] |
UK |
Median (calculated) |
|
|
|
|
| 45 yr: 4.5 |
|
|||||
| 55 yr: 5.5 |
|
|||||
| 65 yr: 6.5 |
|
|||||
| 75 yr: 6.5 |
|
|||||
| 85 yr: 7.5 |
|
|||||
| [7] |
Denmark |
mean 5 (calculated) |
|
|
|
|
| [6] |
Ireland |
median 5.4 (calculated) |
|
55 |
|
|
| [15]* |
UK |
NS |
|
|
|
28 |
| [19] |
USA |
NS |
33 |
|
|
93 |
| [22] |
UK |
PSA > 4 |
85.8 |
|
|
|
| GPs |
78.4 |
|||||
| General surgeons |
85.3 |
|||||
| Geriatricians |
100 |
|||||
| FHSA |
|
|||||
| [17] |
Japan |
PSA > 4 |
73 |
|
|
20 |
| [16] |
USA |
PSA 4-10 |
Age specific: |
|
|
|
| 50–59 years: 69 | ||||||
| 60–69 years: 67 | ||||||
| 70–74 years: 58 | ||||||
| 75–79 years: 52 | ||||||
| ≥ 80 years: 45 | ||||||
| [20] |
USA |
NS |
Most doctors refer with PSA 4-10 |
|
|
13 |
| [25] | USA | PSA > 4 | 67.8 |
Abbreviations: yr year; NS Not Specified; GP General Practitioner; FHSA Family Health Service Advisor.
* abstract only.